India to Saudi Arabia: Tacrolimus Export Trade Route

The India to Saudi Arabia Tacrolimus corridor is one of India's established pharmaceutical export routes, with 19 shipments documented worth a combined $4.2M USD. The route is dominated by DR REDDY S LABORATORIES LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's tacrolimus manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $219.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 14.6%, placing it at rank #18 among India's top tacrolimus export destinations globally.

On the import side, key buyers of Indian tacrolimus in Saudi Arabia include SAUDI PHARMACEUTICAL IND MED APPL CORP SPIMACO ADDWAEIH, SAUDI PHAMACEUTICAL IND MED APPL CO, SAUDI PHARMACEUTICAL IND.& MED and 6 others. SAUDI PHARMACEUTICAL IND MED APPL CORP SPIMACO ADDWAEIH is the single largest importer with 3 shipments valued at $1.3M USD.

India's tacrolimus exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. DR REDDY S LABORATORIES LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD — together account for 100% of total trade value on this route. The average shipment value of $219.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as crotal 1 mg tacrolimus capsules 1 mg 50's pack 49626 x 50's pack = 2481300no's and crotal 5mg (tacrolimus capsules 5mg) (10 , suggesting that buyers in Saudi Arabia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SAUDI PHARMACEUTICAL IND MED APPL CORP SPIMACO ADDWAEIH is the largest importer with 3 shipments worth $1.3M USD — representing 31% of all tacrolimus imports from India on this route. A total of 9 buyers are active on this corridor.